Advertisement

Topics

Vaxart to Present at Two Upcoming Medical Meetings

17:35 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Vaxart, Inc. (NASDAQ: VXRT), a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that new preclinical data on its intranasal Chiku...

Other Sources for this Article

Stern Investor Relations
Carl Mauch, 212-362-1200
vaxart@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Vaxart to Present at Two Upcoming Medical Meetings"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...